← Eichor
Condition: Papulopustular Rosacea Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Papulopustular Rosacea

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Pap
Phase 2 · 1 location(s) · Novartis Pharmaceuticals · NCT07681271Rosacea Radiofrequency Microneedling
NA · 1 location(s) · University of Miami · NCT06801717Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
Phase 2 · 1 location(s) · Narrows Institute for Biomedical Research · NCT06952517
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.